These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18779361)

  • 1. Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.
    Petraitiene R; Petraitis V; Hope WW; Mickiene D; Kelaher AM; Murray HA; Mya-San C; Hughes JE; Cotton MP; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4121-9. PubMed ID: 18779361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Hope WW; Walsh TJ
    Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S643-51. PubMed ID: 26567283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of
    Petraitiene R; Petraitis V; Maung BBW; Mansbach RS; Hodges MR; Finkelman MA; Shaw KJ; Walsh TJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361304
    [No Abstract]   [Full Text] [Related]  

  • 4. Population pharmacokinetics of micafungin in neonates and young infants.
    Hope WW; Smith PB; Arrieta A; Buell DN; Roy M; Kaibara A; Walsh TJ; Cohen-Wolkowiez M; Benjamin DK
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2633-7. PubMed ID: 20308367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.
    Hope WW; Mickiene D; Petraitis V; Petraitiene R; Kelaher AM; Hughes JE; Cotton MP; Bacher J; Keirns JJ; Buell D; Heresi G; Benjamin DK; Groll AH; Drusano GL; Walsh TJ
    J Infect Dis; 2008 Jan; 197(1):163-71. PubMed ID: 18171300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis.
    Auriti C; Falcone M; Ronchetti MP; Goffredo BM; Cairoli S; Crisafulli R; Piersigilli F; Corsetti T; Dotta A; Pai MP
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7333-7339. PubMed ID: 27697761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach.
    Warn PA; Livermore J; Howard S; Felton TW; Sharp A; Gregson L; Goodwin J; Petraitiene R; Petraitis V; Cohen-Wolkowiez M; Walsh TJ; Benjamin DK; Hope WW
    Antimicrob Agents Chemother; 2012 Feb; 56(2):708-14. PubMed ID: 22123680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
    Jafari HS; Sáez-Llorens X; Severien C; Parras F; Friedland I; Rinderknecht S; Ehrett S; Olsen KD; Abramowsky C; McCracken GH
    Antimicrob Agents Chemother; 1994 Jan; 38(1):83-9. PubMed ID: 7511361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
    Cross SA; Scott LJ
    Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shunt lock therapy with micafungin to treat shunt-associated Candida albicans meningitis in an infant.
    Auriti C; Piersigilli F; Ronchetti MP; Campi F; Amante PG; Falcone M; Goffredo BM
    J Antimicrob Chemother; 2016 Jul; 71(7):2060-1. PubMed ID: 27009029
    [No Abstract]   [Full Text] [Related]  

  • 11. Discrepancy of in-vitro data and clinical efficacy of micafungin against Candida tropicalis endophthalmitis.
    Mochizuki K; Murase H; Yasuda Y; Suematsu H; Yamagishi Y; Mikamo H
    J Infect Chemother; 2012 Oct; 18(5):786-9. PubMed ID: 22740188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.
    McCarthy MW; Petraitiene R; Walsh TJ
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida meningitis in an immunocompetent patient detected through (1→3)-beta-d-glucan.
    Farrugia MK; Fogha EP; Miah AR; Yednock J; Palmer HC; Guilfoose J
    Int J Infect Dis; 2016 Oct; 51():25-26. PubMed ID: 27590564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular penetration of micafungin in patient with Candida albicans endophthalmitis.
    Mochizuki K; Suemori S; Udo K; Komori S; Ohkusu K; Yamada N; Ogura S
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):531-3. PubMed ID: 21751880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis.
    Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Moradi PW; Sussman-Straus GE; Naing E; Kovanda LL; Finkelman MA; Walsh TJ
    Med Mycol; 2021 Feb; 59(2):189-196. PubMed ID: 33313821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels.
    Ostrosky-Zeichner L; Paetznick VL; Rodriguez J; Chen E; Sheehan DJ
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1639-41. PubMed ID: 19139291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
    Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152
    [No Abstract]   [Full Text] [Related]  

  • 18. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
    Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
    J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Candidiasis].
    Imamura Y; Izumikawa K; Kohno S
    Nihon Rinsho; 2008 Dec; 66(12):2341-4. PubMed ID: 19069102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.
    Pfaller MA; Diekema DJ; Andes D; Arendrup MC; Brown SD; Lockhart SR; Motyl M; Perlin DS;
    Drug Resist Updat; 2011 Jun; 14(3):164-76. PubMed ID: 21353623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.